4
Changes in Ownership
Outlook Therapeutics, Inc. Filed Acc 0001209191-20-053873
Options or other derivatives
- Director acquired 450,846 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Haddadin Yezan Munther · Director
Table II: Derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-10-01 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +290,372 | 290,372 | D | ||
| 2020-10-05 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +160,474 | $0.51 | $82,500 | 160,474 | D |
Loading xslF345X03/doc4.xml…